Sabra Health Care REIT Q4 2023 Earnings Report
Key Takeaways
Sabra Health Care REIT announced its Q4 2023 results, with key highlights including a net income of $0.07 per diluted common share, FFO of $0.30, Normalized FFO of $0.32, and AFFO of $0.32. The company expanded its relationship with Ignite Medical Resorts through the acquisition of two skilled nursing facilities. Sabra also introduced 2024 earnings guidance and declared a quarterly cash dividend of $0.30 per share of common stock.
Net Income was $0.07 per diluted common share.
FFO was $0.30 per diluted common share.
Normalized FFO was $0.32 per diluted common share.
AFFO was $0.32 per diluted common share.
Sabra Health Care REIT
Sabra Health Care REIT
Sabra Health Care REIT Revenue by Segment
Forward Guidance
Sabra introduced 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): Net Income: $0.53 - $0.57, FFO: $1.33 - $1.37, Normalized FFO: $1.34 - $1.38, AFFO: $1.38 - $1.42, Normalized AFFO: $1.39 - $1.43. Earnings guidance above assumes no 2024 acquisition or disposition activity.
Revenue & Expenses
Visualization of income flow from segment revenue to net income